Lina B A R, Bär A
TNO Nutrition and Food Research, P.O. Box 360, 3700 AJ Zeist, The Netherlands.
Regul Toxicol Pharmacol. 2004 Jun;39 Suppl 1:S27-33. doi: 10.1016/j.yrtph.2004.05.005.
The oral toxicity of alpha-cyclodextrin (alpha-CD) was examined in a 13-week feeding study in which groups of Beagle dogs received alpha-CD in the diet at concentrations of 0 (control), 5, 10, or 20% (4 dogs/sex/group). No treatment-related changes were noted in behavior or appearance of the dogs and no mortalities occurred. Diarrhea occurred in all alpha-CD groups. The incidence and severity of diarrhea increased with increasing dietary levels of alpha-CD and was more pronounced in males than females. Nonetheless, all dogs remained in good health and gained weight. Food intake was slightly increased and food efficiency was slightly decreased in the 20% alpha-CD group. However, these changes did not reach statistical significance. No treatment-related differences were observed with respect to ophthalmoscopic examinations, hematological parameters, clinicochemical analyses of the plasma, and semiquantitative urine analyses. Only the urinary pH was slightly below control levels in males (p > 0.05) and females (p < 0.05) of the 20% alpha-CD group. No abnormalities were seen at necropsy that could be attributed to the treatment. The organ weight data revealed cecal enlargement in the 10 and 20% alpha-CD groups (significant only in males). The relative weight of the colon was also slightly increased in the 10 and 20% alpha-CD groups (significant only in females of the 10% alpha-CD group). On microscopic examination, no treatment-related alterations were observed in any of the various organs and tissues. In conclusion, transient diarrhoea, enlargement of the cecum and colon and a slightly increased acidity of the urine were the only treatment-related effects. These changes are well-known physiological responses to the presence of high amounts of not digested, fermentable carbohydrates in the lower gut. They are known to be reversible on cessation of the treatment and are not associated with histological alterations of the intestinal tissues. It is concluded, therefore, that the high dose level, at which the male and female dogs consumed about 9.8 and 10.4 g alpha-CD/kg bw/d, respectively, is the NOAEL of this 13-week toxicity study.
在一项为期13周的喂养研究中,对α-环糊精(α-CD)的口服毒性进行了检测。在该研究中,将比格犬分组,每组雌雄各4只,分别给予浓度为0(对照)、5%、10%或20%的含α-CD饲料。未观察到与处理相关的犬行为或外观变化,也未出现死亡情况。所有α-CD组均出现腹泻。腹泻的发生率和严重程度随饲料中α-CD水平的升高而增加,且雄性比雌性更明显。尽管如此,所有犬只仍保持健康且体重增加。20%α-CD组的食物摄入量略有增加,食物利用率略有下降。然而,这些变化未达到统计学显著性。在眼科检查、血液学参数、血浆临床化学分析和半定量尿液分析方面,未观察到与处理相关的差异。仅20%α-CD组雄性(p>0.05)和雌性(p<0.05)的尿液pH略低于对照水平。尸检未发现可归因于处理的异常情况。器官重量数据显示,10%和20%α-CD组出现盲肠肿大(仅雄性显著)。10%和20%α-CD组结肠的相对重量也略有增加(仅10%α-CD组雌性显著)。显微镜检查未在任何器官和组织中观察到与处理相关的改变。总之,短暂腹泻、盲肠和结肠肿大以及尿液酸度略有增加是仅有的与处理相关的影响。这些变化是对下消化道中存在大量未消化的可发酵碳水化合物的众所周知的生理反应。已知在停止处理后这些变化是可逆的,且与肠道组织的组织学改变无关。因此得出结论,在该13周毒性研究中,雄性和雌性犬分别摄入约9.8和10.4 gα-CD/kg bw/d的高剂量水平是无观察到有害作用水平(NOAEL)。